









Markets
/
Stocks
/
nasdaq-slp
/

Simulations Plus Inc

SLP

View Detailed Chart

12.800USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

257.49MMarket Cap

35.47P/E TTM



Simulations Plus Inc

12.800

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-1.69%

5 Days

-3.25%

1 Month

-27.89%

6 Months

-62.52%

Year to Date

-54.11%

1 Year

-66.84%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

BUY

Current Rating

25.333

Target Price

97.92%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Simulations Plus Inc

SLP

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Strong sell

Sell(11)

Neutral(1)

Buy(0)

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.617

Neutral

RSI(14)

27.661

Sell

STOCH(KDJ)(9,3,3)

34.718

Sell

ATR(14)

0.871

Low Volatility

CCI(14)

-127.373

Sell

Williams %R

86.513

Oversold

TRIX(12,20)

-1.712

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

13.198

Sell

MA10

13.179

Sell

MA20

14.340

Sell

MA50

19.985

Sell

MA100

24.600

Sell

MA200

27.859

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Ticker SymbolSLP

CompanySimulations Plus Inc

CEOMr. Shawn M. O'Connor

Websitehttps://www.simulations-plus.com/